SCHEMBL6000469

SCHEMBL6000469

O=C(O)c1ccc(NCc2nc(-c3ccc(C(=O)Nc4ccc(C5CCCCC5)cc4)cc3)cs2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 3/20 0.53
HDAC6 Q9UBN7 3/20 0.53
HDAC3 O15379 2/20 0.53
HDAC11 Q96DB2 2/20 0.53
DEGS1 O15121 1/20 0.50
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.44
NAMPT P43490 3/20 0.44
MAPK1 P28482 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
TRPA1 O75762 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5999047 0.90 HDAC3 (0.50) HDAC8HDAC6HDAC3HDAC11DEGS1
SCHEMBL5585410 0.89 HDAC3 (0.53) HDAC8HDAC6HDAC3HDAC11DEGS1
SCHEMBL5585928 0.88 HDAC3 (0.52) HDAC8HDAC6HDAC3HDAC11DEGS1
SCHEMBL6000108 0.86 MRE11 (0.41) HDAC8HDAC6HDAC3HDAC11MEN1
SCHEMBL6000178 0.85 HRH3 (0.44) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL5585937 0.84 MEN1 (0.64) HDAC8HDAC6HDAC3HDAC11DEGS1
SCHEMBL5585254 0.83 HDAC3 (0.48) HDAC8HDAC6HDAC3HDAC11DEGS1
SCHEMBL6000640 0.82 MRE11 (0.44) HDAC8HDAC6MEN1KMT2ANPC1
SCHEMBL6001067 0.81 RAB9A (0.42) HDAC8HDAC6HDAC3HDAC11MEN1
SCHEMBL5585572 0.81 HDAC3 (0.52) HDAC8HDAC6HDAC3HDAC11DEGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 HDAC8 1663/4885HDAC6 1119/4885HDAC3 357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.